Lanean...
A potential therapy for chordoma via antibody-dependent cell-mediated cytotoxicity (ADCC) employing NK or high affinity NK (haNK) cells in combination with cetuximab
OBJECTIVE: Chordoma is a rare bone tumor derived from the notochord, and is resistant to conventional therapies such as chemotherapy, radiotherapy, and targeting therapeutics. Expression of epidermal growth factor receptor (EGFR) in a large proportion of chordoma specimens indicates that chordoma ma...
Gorde:
| Argitaratua izan da: | J Neurosurg |
|---|---|
| Egile Nagusiak: | , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6459012/ https://ncbi.nlm.nih.gov/pubmed/28753113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3171/2017.1.JNS162610 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|